Understanding interactions between Chinese medicines and pharmaceutical drugs in integrative healthcare

Kelvin Chan

doi:10.1007/s11655-014-1794-y

Your Location：

Home >

Browse articles >

Understanding interactions between Chinese medicines and pharmaceutical drugs in integrative healthcare

Updated：2021-08-27

- Understanding interactions between Chinese medicines and pharmaceutical drugs in integrative healthcare
- Chinese Journal of Integrative Medicine Vol. 21, Issue 2, Pages: 83-89(2015)
- Affiliations：
  
  1. The National Institute of Complementary Medicine, University of Western Sydney,Sydney,Australia
  2. Faculty of Pharmacy, The University of Sydney,Sydney,Australia
- Author bio：
- Funds：
- DOI：10.1007/s11655-014-1794-y
  CLC：
- Published：2015，
  
  Published Online：19 December 2014，
Scan for full text
Chan, K. Understanding interactions between Chinese medicines and pharmaceutical drugs in integrative healthcare., Chin. J. Integr. Med. 21, 83–89 (2015). https://doi.org/10.1007/s11655-014-1794-y

Kelvin Chan. Understanding interactions between Chinese medicines and pharmaceutical drugs in integrative healthcare. [J]. Chinese Journal of Integrative Medicine 21(2):83-89(2015)
Chan, K. Understanding interactions between Chinese medicines and pharmaceutical drugs in integrative healthcare., Chin. J. Integr. Med. 21, 83–89 (2015). https://doi.org/10.1007/s11655-014-1794-y DOI：

Kelvin Chan. Understanding interactions between Chinese medicines and pharmaceutical drugs in integrative healthcare. [J]. Chinese Journal of Integrative Medicine 21(2):83-89(2015) DOI： 10.1007/s11655-014-1794-y.

摘要

In the 21st century

the public are more informed

mainly via the Internet

about health and medical products and have become more knowledgeable about matters relating to their health conditions and well-being in curing and preventing illnesses. They often self-medicate themselves with various health products and over-the-counter (OTC) medicines apart from prescribed pharmaceutical drugs (PD). Some of those non-prescribed products may have doubtful quality control and contain harmful additives or unchecked ingredients; thus their usefulness is in doubt. The increasing popularity world-wide of using Chinese medicines (CM) and related OTC functional products has raised concerns over their concomitant use with PD and the consequential adverse effects. In most cases the alleged causes of adverse effects are linked with herbal sources

although the authorised information on the interactions between CM-PD is not plentiful in the literature. There is an urgent need for such a data base. The future professionals in health and medical care should be knowledgeable or aware of what their patients have been taking or given. In actual practice the patients may receive both treatments intentionally or unintentionally

with or without the awareness of the practitioner. In these situations a reliable database for interactions between CM-PD will be extremely useful for consultation when treatment problems appear or during emergency situations. Their combining of medications may be involved with possible outcomes of adverse reactions or beneficial effects. Such a database will be welcomed by both practitioners of herbal medicines and orthodox medicine practitioners in the emerging trend of integrative medicine. The author has been involved in various research projects of basic and clinical aspects in mainly CM among other herbal and PD. Examples will be given largely on those related to these disciplines as illustrations in this overview.

Abstract

In the 21st century

the public are more informed

mainly via the Internet

关键词

Chinese medicines and pharmaceutical drugs interactionsadverse effectsbeneficial co-treatmentherb-drug interactionpossible mechanismsfuture directions

Keywords

Chinese medicines and pharmaceutical drugs interactionsadverse effectsbeneficial co-treatmentherb-drug interactionpossible mechanismsfuture directions

references

Helmut Kaiser Consultancy HKC22. Traditional Chinese medicine: with overview worldwide market, development, products and companies. Available at: www.hkc22.com.

Chan K. Chinese medicinal materials and their interface with Western medical concepts. J Ethnopharmacol 2005;96:1–18.

Dobos G, Tao I. The model of Western integrative medicine: The role of Chinese medicine. Chin J Integr Med 2011;17:11–20.

Lu AP, Ding XR, Chen KJ. Current situation and progress in integrative medicine in China. Chin J Integr Med 2008;14:234–240.

Fugh-Berman A. Herb-drug interactions. Lancet 2000;355:134–138.

Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs 2009;69:1777–1798.

Bush TM, Rayburn KS, Holloway SW, Sanchez-Yamamoto DS, Allen BL, Lam T, et al. Adverse interactions between herbal and dietary substances and prescription medications: a clinical survey. Altern Therap Health Med 2007;13:30–35.

Mao JJ, Palmer CS, Healy KE, Desai K, Amsterdam J. Complementary and alternative medicine use among cancer survivors: a population-based study. J Cancer Survivorship 2010. DOI: 10.1007/s11764-010-0153-7.

Chan K, Cheung L, eds. Interactions between Chinese herbal medicinal products and orthodox drugs. New York, Oxford & Philadelphia; Taylor & Francis Group; 2000:176.

Jiang, M, Lu C, Zhang C, Yang J, Tan Y, Lu A, et al. Syndrome differentiation in modern research of traditional Chinese medicine. J Ethnopharmcol 2012;140:634–642.

Chan K, Poon J, Poon S, Jiang M, Lu A. An overview on evidence-based medicine and medical informatics in traditional Chinese medicine practice. In: Poon J, Poon S, eds. Data analysis for traditional Chinese medicine research. Switzerland: Springer International Publishing Ltd., 2014:227–248.

Williamson EM, Lorenc A, Booker A, Robinson N. The rise of traditional Chinese medicine and its materia medica: a comparison of the frequency and safety of materials and species used in Europe and China. J Ethnopharmacol 2013;49:453–462.

Mills S. Herbal medicines: research strategies. In: Fundamentals of complementary and alternative medicine. London International Edition; 1996:394–407.

National Center for Complementary and Alternative Medicine (NCCAM): What research will NCCAM fund? Available at: http://nccam.nih.gov/grants/whatnccamfunds.

GPTCM. Good Practice in Traditional Chinese Medicine Research Consortium supported by EU-FP7 fund. J Ethnopharmacol 2012;140:455–644.

National Health and Medical Research Council, Complementary medicine gets a boost. Available at: https://www.nhmrc.gov.au/grants/outcomes-fundingrounds/historical-information-capacity-building-grants/complementary-and-alt.

Tsang I, Huang S, Koelhler B. Integration of Chinese medicine and Western medicine in clinical practice (patient care): past, present and a proposed model for the future. Chin J Integr Med 2013;19:83–85.

Alsanand S, Williumson EM, Howard RL Cancer patient at risk of herbal/food supplement-drug interactions: a systematic review. Phytother Res 2014; DOI: 10.1002/ptr.5213.

Global Alliance for Chronic diseases. Released on 26th July 2013 by Members of Global Alliance for Chronic Diseases to fund landmark research initiative to reduce impact of diabetes. Available at: http://www.diabetes.co.uk/globaldiabetes/diabetes-in-china.html.

FULL TEXT LINK

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Drug discovery enters a new era with multi-target intervention strategy

Acupuncture: Complications are preventable not adverse events

Potential herb-drug interaction in the prevention of cardiovascular diseases during integrated traditional and western medicine treatment

Alterations of Gefitinib Pharmacokinetics by Co-administration of Herbal Medications in Rats

Clinical Efficacy and Safety of Bathing with Chinese Medicine Taohong Siwu Decoction (桃红四物汤) for Treatment of Diffuse Cutaneous Systemic Sclerosis: A Randomized Placebo-Controlled Trial

Related Author

No data

Related Institution

Centre for Cancer and Inflammation Research, School of Chinese Medicine, Hong Kong Baptist University

State Key Laboratory for Quality Research in Chinese Medicines, Macau University of Science and Technology, Taipa, Macau

Institute of Chinese Medicine, The Chinese University of Hong Kong

Cardiovascular Department, Shanghai Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

College of Pharmacy, Catholic University of Daegu, Gyeongbuk, Republic of Korea

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰